Clincosm LogoSign in Get a demo

stage iiic melanoma

Showing 1 - 19 of 19
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma Trial in United States (trametinib, laboratory biomarker analysis,

Completed
Has Results
  • Recurrent Melanoma
  • +3 more
  • Washington, District of Columbia
  • +3 more
May 4, 2021

Melanoma, Malignant Melanoma, Stage IIIA Melanoma Trial in Orange (procedure, other, drug)

Completed
Has Results
  • Melanoma
  • +4 more
  • therapeutic conventional surgery
  • +3 more
  • Orange, California
    Chao Family Comprehensive Cancer Center
Dec 30, 2020

Recurrent Melanoma, Stage IIIA Melanoma, Stage IIIB Melanoma Trial in United States (aldesleukin, ipilimumab, laboratory

Completed
  • Recurrent Melanoma
  • +4 more
  • aldesleukin
  • +2 more
  • Maywood, Illinois
  • +4 more
Jun 17, 2020

Recurrent Melanoma, Stage IIIA Melanoma, Stage IIIB Melanoma Trial in United States (other, drug, procedure)

Completed
Has Results
  • Recurrent Melanoma
  • +4 more
  • cytology specimen collection procedure
  • +4 more
  • Scottsdale, Arizona
  • +7 more
Dec 16, 2019

Stage IIIC Melanoma, Stage IV Melanoma Trial in United States (Denileukin diftitox)

Completed
  • Stage IIIC Melanoma
  • Stage IV Melanoma
  • Denileukin diftitox
  • Encinitas, California
  • +9 more
Feb 28, 2019

Recurrent Melanoma, Stage IIA Melanoma, Stage IIB Melanoma Trial in Rochester (drug, biological, other)

Completed
  • Recurrent Melanoma
  • +7 more
  • Montanide ISA 51 VG
  • +4 more
  • Rochester, Minnesota
    Mayo Clinic
Oct 4, 2018

Recurrent Melanoma, Recurrent Pancreatic Cancer, Recurrent Renal Cell Cancer Trial in Winston-Salem (siRNA-transfected

Completed
  • Recurrent Melanoma
  • +11 more
  • siRNA-transfected peripheral blood mononuclear cells APN401
  • laboratory biomarker analysis
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Jul 2, 2018

Extraocular Extension Melanoma, Metastatic Intraocular Melanoma, Recurrent Intraocular Melanoma Trial in Buffalo (axitinib,

Terminated
Has Results
  • Extraocular Extension Melanoma
  • +11 more
  • Buffalo, New York
    Roswell Park Cancer Institute
May 8, 2018

Recurrent Melanoma, Stage IIB Melanoma (Locally Advanced), Stage IIC Melanoma (Locally Advanced) Trial in Nashville (dabrafenib,

Terminated
Has Results
  • Recurrent Melanoma
  • +6 more
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
Jun 20, 2017

Recurrent Melanoma, Stage IIIA Melanoma, Stage IIIB Melanoma Trial in Nashville (diagnostic test, other, device)

Terminated
Has Results
  • Recurrent Melanoma
  • +4 more
  • [18F]fluorodeoxyglucose
  • +3 more
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
Apr 12, 2017

Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma Trial in Boston (dinaciclib, pharmacological study, laboratory

Terminated
Has Results
  • Stage IIIB Melanoma
  • +2 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Mar 3, 2017

Recurrent Melanoma, Stage IA Melanoma, Stage IB Melanoma Trial in Portland (HPV 16 E7:12-20, gp100:209-217(210M), laboratory

Completed
Has Results
  • Recurrent Melanoma
  • +8 more
  • HPV 16 E7:12-20
  • +2 more
  • Portland, Oregon
    Providence Portland Medical Center
Dec 28, 2016

Recurrent Melanoma, Stage IIIc Melanoma, Stage IV Melanoma Trial in Nashville (other, procedure, genetic)

Terminated
Has Results
  • Recurrent Melanoma
  • +2 more
  • laboratory biomarker identification and analysis
  • +4 more
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
Apr 21, 2016

Basal Cell Carcinoma of the Skin, Eccrine Carcinoma of the Skin, Recurrent Adult Soft Tissue Sarcoma Trial in Bronx (isolated

Withdrawn
  • Basal Cell Carcinoma of the Skin
  • +10 more
  • isolated limb perfusion
  • +2 more
  • Bronx, New York
    Albert Einstein College of Medicine
Jul 22, 2015

Acral Lentiginous Malignant Melanoma, Recurrent Melanoma, Stage IIIA Melanoma Trial in United States (imatinib mesylate,

Completed
Has Results
  • Acral Lentiginous Malignant Melanoma
  • +5 more
  • imatinib mesylate
  • laboratory biomarker analysis
  • Los Angeles, California
  • +7 more
Dec 15, 2014

Recurrent Melanoma, Stage IIIA Melanoma, Stage IIIB Melanoma Trial in Atlanta, Boston, Richmond (cabozantinib-s-malate,

Terminated
  • Recurrent Melanoma
  • +5 more
  • Atlanta, Georgia
  • +2 more
Sep 23, 2014

Recurrent Melanoma, Stage IIIA Melanoma, Stage IIIB Melanoma Trial in United States (Akt inhibitor MK2206, selumetinib,

Terminated
Has Results
  • Recurrent Melanoma
  • +4 more
  • Akt inhibitor MK2206
  • +2 more
  • Atlanta, Georgia
  • +3 more
May 16, 2014

Recurrent Melanoma, Stage IIIA Melanoma, Stage IIIB Melanoma Trial in New Haven, Minneapolis (dasatinib)

Completed
Has Results
  • Recurrent Melanoma
  • +4 more
  • New Haven, Connecticut
  • +1 more
Apr 29, 2014

Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma Trial in Bronx, New York (drug, other, procedure)

Withdrawn
  • Stage IIIB Melanoma
  • +2 more
  • gamma-secretase/Notch signalling pathway inhibitor RO4929097
  • +3 more
  • Bronx, New York
  • +1 more
Jan 30, 2013